HPG-30 immunogen using the p17 core protein of HIV: Received clearance from California regulators to start testing in infected people. The trial should start by

CEL-SCI Corp. (CELI), Alexandria, Va. Product: HPG-30 immunogen using the p17 core protein of HIV Indication: HIV infection Status: Received clearance from California regulators to start testing in in...